These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9029092)

  • 41. Th2-type cytokines in the "infectious" tolerance pathway.
    Onodera K; Hancock WW; Graser E; Volk HD; Lehmann M; Chandraker A; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):1290-1. PubMed ID: 9123311
    [No Abstract]   [Full Text] [Related]  

  • 42. Transfer of "infectious" cardiac allograft tolerance induced by donor-specific transfusion.
    Kataoka M; Shimizu Y; Margenthaler JA; Landeros K; Otomo N; Flye MW
    Surgery; 2002 Aug; 132(2):167-72. PubMed ID: 12219007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfer of allograft specific tolerance requires CD4+CD25+T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens.
    Hall BM; Plain KM; Verma ND; Tran GT; Boyd R; Robinson CM; Nicolls MR; Berger ME; Nomura M; Hodgkinson SJ
    Transplantation; 2007 Apr; 83(8):1075-84. PubMed ID: 17452898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
    Sayegh MH; Akalin E; Hancock WW; Russell ME; Carpenter CB; Linsley PS; Turka LA
    J Exp Med; 1995 May; 181(5):1869-74. PubMed ID: 7536798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats.
    Josien R; Pannetier C; Douillard P; Cantarovich D; Menoret S; Bugeon L; Kourilsky P; Soulillou JP; Cuturi MC
    Transplantation; 1995 Nov; 60(10):1131-9. PubMed ID: 7482721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion.
    Isobe M; Suzuki J; Yamazaki S; Yazaki Y; Horie S; Okubo Y; Maemura K; Yazaki Y; Sekiguchi M
    Circulation; 1997 Oct; 96(7):2247-53. PubMed ID: 9337197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation.
    Kataoka M; Margenthaler JA; Ku G; Flye MW
    J Immunol; 2003 Jul; 171(1):204-11. PubMed ID: 12816999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of acquired thymic tolerance induced by a single major histocompatibility complex class I peptide with the dominant epitope: differential analysis of regulatory cytokines in the lymphoid and intragraft compartments.
    Oluwole SF; Chowdhury NC; Ingram M; Garrovillo M; Jin MX; Agrawal S
    Transplantation; 1999 Aug; 68(3):418-29. PubMed ID: 10459547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients.
    Heidecke CD; Zantl N; Maier S; Sewczik T; Westerholt S; Jakobs F; Westerholt A; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1998 Nov; 66(10):1354-61. PubMed ID: 9846522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
    Plain KM; Chen J; Merten S; He XY; Hall BM
    Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
    Shirwan H; Barwari L; Khan NS
    Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-CD4 induced rat heart tolerance: no presence of primed T cells and regulatory mechanisms for cytotoxic T cells.
    Yamamoto T; Yamaguchi J; Nakayama E; Kanematsu T
    Transpl Immunol; 2000 Jun; 8(2):101-7. PubMed ID: 11005315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines.
    Plain KM; Fava L; Spinelli A; He XY; Chen J; Boyd R; Davidson CL; Hall BM
    Transplantation; 1997 Dec; 64(11):1559-67. PubMed ID: 9415556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells.
    Andoins C; de Fornel D; Annat J; Dutartre P
    Transplantation; 1996 Dec; 62(11):1543-9. PubMed ID: 8970605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.
    Motoyama K; Arima T; Lehmann M; Flye MW
    Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TGF-beta1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down-regulation.
    Gagne K; Brouard S; Guillet M; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 Oct; 31(10):3111-20. PubMed ID: 11592088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
    Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
    Blood; 2009 Jan; 113(2):479-87. PubMed ID: 18827184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses.
    He XY; Chen J; Verma N; Plain K; Tran G; Hall BM
    Transplantation; 1998 May; 65(9):1145-52. PubMed ID: 9603159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.